Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

10. September 2015 09:00 ET | Quelle: BrainsWay Ltd.

Brainsway Expands Management Team With Appointment of Joseph Perekupka as VP of Sales Operations, North America

HAR HAHOZVIM, Israel, Sept. 10, 2015 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN), a leading company developing revolutionary brain disorder treatments, announced that Joseph Perekupka has joined...
17. August 2015 15:00 ET | Quelle: BrainsWay Ltd.

Brainsway Appoints Avi Posen as VP Global Sales

JERUSALEM, Aug. 17, 2015 (GLOBE NEWSWIRE) -- Brainsway Ltd (TASE:BRIN) announced this week that it has appointed Avi Posen to the position of VP Global Sales, effective August 16th, 2015. Posen...
30. Dezember 2014 08:00 ET | Quelle: BrainsWay Ltd.

Brainsway Launches Distribution Company in the U.S.

JERUSALEM, Dec. 30, 2014 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) announced that in light of developments in the U.S. market, including the increased interest in Brainsway's technology and...
15. Dezember 2014 08:00 ET | Quelle: BrainsWay Ltd.

Brainsway Receives IDE Approval From FDA for Launching Pivotal PTSD Multi-Center Trial

JERUSALEM, Dec. 15, 2014 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) announced that it received an IDE (Investigational Device Exemptions) approval from the FDA for launching a Multi-Center trial...
04. Dezember 2014 08:00 ET | Quelle: BrainsWay Ltd.

Brainsway Receives CE Approvals for Treating Multiple Sclerosis (MS), Stroke and Obsessive Compulsive Disorder (OCD)

JERUSALEM, Dec. 4, 2014 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) announced that it received a CE Marketing Approval, enabling it to immediately market and sell Brainsway Deep TMS (Deep...
13. Oktober 2014 09:00 ET | Quelle: BrainsWay Ltd.

Brainsway Wins 2014 FLC Mid-Atlantic Regional Award for Excellence in Technology Transfer

JERUSALEM, Oct. 13, 2014 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) announced that its Deep TMS treatment has won the 2014 Federal Laboratory Consortium for Technology Transfer (FLC) Mid-Atlantic...
30. September 2014 08:39 ET | Quelle: BrainsWay Ltd.

Brainsway Deep TMS Brings Substantial Improvement to OCD Patients in Deep TMS Study

JERUSALEM, Sept. 30, 2014 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to report substantial improvement in OCD (Obsessive-Compulsive Disorder) patients following Brainsway Deep TMS...
05. Juni 2014 15:58 ET | Quelle: BrainsWay Ltd.

Results Announced for Study of Major Depression Patients Who Did Not Respond to Medication Treatments

JERUSALEM, June 5, 2014 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce the final results for a study examining the safety and effectiveness of Brainsway's technology for...
19. Dezember 2013 08:32 ET | Quelle: BrainsWay Ltd.

Brainsway Receives FDA Approval of IDE for Obsessive-Compulsive Disorder Study

JERUSALEM, Dec. 19, 2013 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that the U.S. Food and Drug Administration ("FDA") has approved an Investigational Device Exemption...
23. September 2013 12:16 ET | Quelle: BrainsWay Ltd.

Brainsway's Deep TMS System to be Marketed and Distributed in Japan

JERUSALEM, Sept. 23, 2013 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) ("Brainsway" or the "Company") is pleased to announce the execution of an agreement for the marketing and distribution of its...

Vorherige Seite